|
ELL expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.99809946366258E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.26790000720689E-09 |
| Normal-vs-Stage2 |
1.66121999999325E-05 |
| Normal-vs-Stage3 |
1.008980E-04 |
| Normal-vs-Stage4 |
6.238100E-04 |
| Stage1-vs-Stage2 |
7.935600E-01 |
| Stage1-vs-Stage3 |
3.679400E-01 |
| Stage1-vs-Stage4 |
9.105200E-01 |
| Stage2-vs-Stage3 |
6.237600E-01 |
| Stage2-vs-Stage4 |
7.577000E-01 |
| Stage3-vs-Stage4 |
5.410400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.41120004570894E-09 |
| Normal-vs-AfricanAmerican |
2.0435999559254E-09 |
| Normal-vs-Asian |
2.231800E-02 |
| Caucasian-vs-AfricanAmerican |
8.092000E-01 |
| Caucasian-vs-Asian |
6.914200E-01 |
| AfricanAmerican-vs-Asian |
5.674400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.90221230065436E-12 |
| Normal-vs-Female |
3.57130000000483E-05 |
| Male-vs-Female |
6.827700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.8956000003012E-07 |
| Normal-vs-Extreme_Weight |
1.01300000054927E-07 |
| Normal-vs-Obese |
4.50939999996347E-06 |
| Normal-vs-Extreme_Obese |
1.06879999961507E-07 |
| Normal_Weight-vs-Extreme_Weight |
5.685000E-01 |
| Normal_Weight-vs-Obese |
1.732410E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.029200E-01 |
| Extreme_Weight-vs-Obese |
3.449800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.487700E-02 |
| Obese-vs-Extreme_Obese |
2.034300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.564200E-02 |
| Normal-vs-Age(41-60Yrs) |
6.62719999988681E-07 |
| Normal-vs-Age(61-80Yrs) |
2.2349899708729E-12 |
| Normal-vs-Age(81-100Yrs) |
1.58188999999087E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.627990E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.597600E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.596000E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.832280E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.863900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.015600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.4212004864147E-10 |
| Normal-VS-Type2 PRCC |
6.70241639966207E-13 |
| Normal-VS-KIRP CIMP |
1.923620E-01 |
| Normal-VS-Unclassified PRCC |
2.569500E-04 |
| Type1 PRCC-VS-Type2 PRCC |
1.862880E-03 |
| Type1 PRCC-VS-KIRP CIMP |
2.297500E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.794400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.648000E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
4.355700E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
1.639620E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.15300002878627E-09 |
| Normal-vs-N1 |
6.210900E-04 |
| Normal-vs-N2 |
7.911600E-02 |
| N0-vs-N1 |
6.734100E-02 |
| N0-vs-N2 |
1.709790E-01 |
| N1-vs-N2 |
9.429400E-01 |
|
|
